Tricida Inc Stock News

Wilmington, Delaware--(Newsfile Corp. - February 8, 2023) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Tricida, Inc. (NASDAQ: TCDA) on behalf of stockh

Tricida Inc., a clinical-stage pharmaceutical company working on a kidney disease drug, has filed for Chapter 11 bankruptcy protection in Delaware, with roughly US$350 million of debt, according to a

The difficult state of the macroeconomic environment in 2022 has had a negative impact on the performance of a number of equity investments. Worries about a recession and a bearish attitude among inve

These industries could be worth looking into to find penny stocks to watch The post What Penny Stocks Industries Are Popular Right Now? appeared first on Penny Stocks to Buy, Picks, News and Informati

SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three and nine months ended September 30, 2022 and provided an update on key init

Trading under $1 penny stocks? Use these tips The post What to Look For in Penny Stocks Under $1, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Check these tips out for trading penny stocks right now The post Buying Cheap Penny Stocks in November? 3 Tips to Use  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks

Are these the reasons you're not profiting with penny stocks? The post Top Reasons You're Not Making Money With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (NASDAQ: TCDA), announced today that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximiz

Tricida (NASDAQ: TCDA ) stock is falling on Monday following the release of poor results from a Phase 3 clinical trial. That trial covers the use of veverimer to treat patients suffering from metaboli

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s abi

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) announced today that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing de

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tricida, Inc. (“Tricida” or the “Company”) (NASDAQ: TCDA) on behalf of the Company's long-term investors.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) announced today that a late-breaking clinical trial abstract on the Phase 3, VALOR-CKD renal outcomes trial has been selected

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) announced today that a late-breaking clinical trial abstract on the Phase 3, VALOR-CKD renal outcomes trial has been selected